The role of high-sensitivity troponin in identifying patients with cardiac allograft rejection
In this cohort, HS-troponin I was able to identify patients with acute cellular rejection. This is the largest Latin American cohort assessing hs-TnI after HT, and the first to explore its performance across specific etiologies, including Chagas disease. Prospective studies may confirm the role of HS-troponin I as a biomarker of acute rejection.
Authors
- André A. Scussel
- Daniel Catto De Marchi (ORCID: https://orcid.org/0000-0002-1753-4741)
- Cristhian Espinoza Romero (ORCID: https://orcid.org/0000-0003-0191-7358)
- M.S. Ávila Grinberg
- Fabiana G. Marcondes‐Braga (ORCID: https://orcid.org/0000-0002-2533-5638)
- Fernando Bacal (ORCID: https://orcid.org/0000-0001-7603-2752)
- Luís Fernando Bernal da Costa Seguro (ORCID: https://orcid.org/0000-0002-7857-9863)
- I.W. Campos (ORCID: https://orcid.org/0000-0002-8822-5997)
- Sandrigo Mangini (ORCID: https://orcid.org/0000-0003-0894-1131)
- Fábio Antônio Gaiotto
- Ana Maria Peixoto Cardoso Duque
Institutions
- Universidade de São Paulo (BR)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100446
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00